'DAUNOMYCIN', A NEW ANTIBIOTIC OF THE RHODOMYCIN GROUP.
D000818:Animals; D018943:Anthracyclines; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor; D006528:Carcinoma, Hepatocellular; D004247:DNA; D004273:DNA, Neoplasm; D003630:Daunorubicin; D006027:Glycosides; D008113:Liver Neoplasms; D051379:Mice; D010600:Pharmacology; D011048:Polarography; D012313:RNA; D012334:RNA, Neoplasm; D051381:Rats; D012106:Research; D014466:Ultraviolet Rays
D018943:Anthracyclines; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D006027:Glycosides; D012334:RNA, Neoplasm; C004977:rhodomycin; D012313:RNA; D004247:DNA; D003630:Daunorubicin
ANTIBIOTICS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; DAUNOMYCIN; DNA, NEOPLASM; EXPERIMENTAL LAB STUDY; GLYCOSIDES; HEPATOMA; MICE; PHARMACOLOGY; POLAROGRAPHY; RATS; RNA, NEOPLASM; ULTRAVIOLET RAYS